Specialty and orphan drugs continue to dominate the development pipeline, and a new report from Optum Rx spotlights three products payers should be watching. The pharmacy benefit manager recently ...

Optum is rolling out a new offering that seeks to make it easier and faster for patients to secure durable medical equipment. The company's Optum Insight division unveiled DME Navigator on Tuesday, ...

A new Optum report highlighting upcoming medications in the drug pipeline is meant as a heads-up for payers as they track developments with a couple of therapies for Alzheimer's disease – lecanemab ...